AM‐Pharma B.V. Archives • NCK Pharma

Pfizer Acquires Minority Interest in AM-Pharma Based on Phase II Trial Results for Recombinant Human Alkaline Phosphatase

Posted on12 May 2015

TagsAcute Kidney Injury, Acute Kidney Injury (AKI) related to sepsis, AM‐Pharma B.V., pfizer, Pfizer Acquires Minority Interest in AM-Pharma, recAP, recombinant human Alkaline Phosphatase, Why Pfizer to acquire AM Pharma

Comments0

AM‐Pharma B.V., a privately held Dutch biopharmaceutical company focused on the development of recombinant human Alkaline Phosphatase (recAP) for inflammatory diseases, and...